Status:
UNKNOWN
Effectiveness of Stereotactic RadioTherapy in Solid Primary Inoperable and Oligometastatic Cancer
Lead Sponsor:
The National Center of Oncology, Azerbaijan
Conditions:
Radiotherapy
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to development of more effective treatment tactics of the stereotactic radiotherapy and radiosurgery alone and together with classic radiation therapy in primary inoperabe...
Detailed Description
Despite the fact that of many investigations in the world clinical researches, the SRT of primary-inoperabel and metastatic solid tumors combined with conventional and conformal radiation therapy meth...
Eligibility Criteria
Inclusion
- Histologically confirmed primary-inoperable solid tumors or oligometastatic cancer.
- Acceptance of patient by surgeon as non-operabel or refusing of surgery.
- No more than 4 metastatic foci in irradiated organ.
- Karnofsky scale more than 60.
- Age ≥18 years.
- Estimated duration of life \>3 months.
- Hemoglobin ≥ 8 g/dl.
- Absolute neutrophil count at least 1,500/mm\^3.
- Platelet count at least 70,000/mm\^3.
- Bilirubin no greater than 1.5 times normal.
- SGOT and SGPT no greater than 3 times normal.
- Creatinine less than 1.5 mg/dL. PT-INR/APTT less than 1.5.
- Last patients data no older than 1 month.
- No prior radiotherapy of same location.
- Prior chemottherapy more than 2 weeks ago.
Exclusion
- Progression of primary site of metastatic cancer.
- Pregnancy or Breast-Feeding.
- Decompensated concomitant diseases.
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2020
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03461822
Start Date
March 1 2013
End Date
January 1 2020
Last Update
March 12 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Center of Oncology
Baku, Azerbaijan, AZ1011